M

MNOV

MNOV

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
MNOV Live QuoteReal-time
$1.33
$0.03(-2.21%)1M
Day Range$1.26 – $1.41
Open$1.32
Previous Close$1.34
Volume115.6K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$68.65M
P/E Ratio (TTM)24.5
Forward P/E8.5
EPS (TTM)$-0.21
Price to Book1.7
Dividend Yield0.65%
Beta (Volatility)0.71
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $1.33 (4%)
Low: $1.22High: $3.90
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$8.25-94.5% upside

Insider Buys

0

$0

Insider Sales

1

$1.73M

Total Volume

$1.73M

1 transactions

Net Activity

$1.73M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
35CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
3
1

3D Investment Partners Pte. Ltd.

Formerly 10% Owner

0 buys1 sells

$1.73M total

Trading History
MNOV insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 25, 2026

1 months ago

3D Investment Partners Pte. Ltd.

Formerly 10% Owner

10% Owner
Sell640.0K$2.70$1.73M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
MNOV Buy Conviction0%
Industry Rank#0 of 563
Volume Contribution0.0%
Total Industry Activity$16.73B

MNOV has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for MNOV

Over the last 90 days, corporate insiders at MNOV (MNOV) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 1 were sales. The total volume of insider trading reached $1.73M.

The net insider activity for MNOV shows a net selling bias of $1.73M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by 3D Investment Partners Pte. Ltd. (Formerly 10% Owner), who traded 640.0K shares valued at $1.73M on Sep 25, 2026.

Live Market News & Developments
Aggregated real-time headlines for MNOV (MNOV)
6 updates

MNOV - Medicinova Inc Stock Price and Quote

Finviz176d ago

We Think MediciNova (NASDAQ:MNOV) Can Afford To Drive Business Growth

Yahoo Finance187d ago

Why Is MediciNova Stock Tumbling Today? - MediciNova (NASDAQ:MNOV)

Benzinga52d ago

MediciNova, Inc. (MNOV) Stock Price History & Data

Traders Union7d ago

symbol__ Stock Quote Price and Forecast

CNN984d ago

MediciNova (NasdaqGM:MNOV) Stock Forecast & Analyst Predictions

Simply Wall St51d ago

FAQs About MNOV Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for MNOV.

Based on SEC Form 4 disclosures, the Insider Confidence Score for MNOV is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 1 sales by company executives over the last 90 days.

The CEO Conviction Index for MNOV is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.